A detailed history of Act Capital Management, LLC transactions in En V Veno Medical Corp stock. As of the latest transaction made, Act Capital Management, LLC holds 401,200 shares of NVNO stock, worth $1.37 Million. This represents 3.48% of its overall portfolio holdings.

Number of Shares
401,200
Previous 401,200 -0.0%
Holding current value
$1.37 Million
Previous $1.52 Million 66.12%
% of portfolio
3.48%
Previous 2.12%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022

BUY
$4.42 - $7.0 $613,054 - $970,900
138,700 Added 52.84%
401,200 $2.56 Million
Q4 2021

Feb 03, 2022

BUY
$6.23 - $10.24 $1.64 Million - $2.69 Million
262,500 New
262,500 $1.73 Million

Others Institutions Holding NVNO

About enVVeno Medical Corp


  • Ticker NVNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 9,469,850
  • Market Cap $32.3M
  • Description
  • enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...
More about NVNO
Track This Portfolio

Track Act Capital Management, LLC Portfolio

Follow Act Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Act Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Act Capital Management, LLC with notifications on news.